Delivery Order SPE2DB20D3103-SPE2DB23FM2C2

Award Date 1/20/23
Potential Completion Date 1/23/23
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The contract has a ceiling value of $1,470.49 and is a Firm Fixed Price Delivery Order that runs through February 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,944.43, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, with a ceiling value of $1,815.41. It is a firm fixed-price, delivery order contract with an ultimate completion date of April 14, 2023. The contract was awarded on April 13, 2023 and was not subject to any set-aside requirements. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,372.85, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of September 7, 2023. There is no set-aside designation, indicating this was a full and open competition. Amerisourcebergen...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB25FM3T6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, and has a ceiling value of $1,212.51. It is a Firm Fixed Price Delivery Order contract with a performance period ending on January 21, 2025. The contract is not designated as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,046.76, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,000.75 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The award, with a ceiling value of $12,287.39, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on December 7, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 8, 2023. The award is not associated with a set-aside designation,...
This federal contract award, valued at $1,391.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $5,667.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a medical product, with an ultimate completion date of November 4, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM2C2
    Delivery Order

This federal contract award, with a total ceiling value of $1,226.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is January 23, 2023.

The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the "doing business as" name Amerisourcebergen. Both Amerisourcebergen Drug Corp and Cencora, Inc. hold significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00 each, that serve as primary vehicles for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 9:44 AM